Strategizing for Regulatory Approval when Designing Clinical Trials for Neurological Gene Therapies
Time: 3:30 pm
day: Conference Day Two
Details:
- Understanding how to set up your clinical trial design to please regulators
- Identifying novel biomarkers to CNS indications to utilize in clinical monitoring
- Accelerating clinical studies with endpoints to show disease modifying effects at a faster rate
